NIST Consortium for Advancement of Genome Editing, 84534 [2024-24514]
Download as PDF
84534
Federal Register / Vol. 89, No. 205 / Wednesday, October 23, 2024 / Notices
DEPARTMENT OF COMMERCE
National Institute of Standards and
Technology
NIST Consortium for Advancement of
Genome Editing
National Institute of Standards
and Technology, Department of
Commerce.
ACTION: Notice of Research Consortium;
Extension of Research Consortium.
AGENCY:
The National Institute of
Standards and Technology (NIST)
extends the duration of the NIST
Consortium for Advancement of
Genome Editing (Genome Editing
Consortium or Consortium). The
Consortium duration was previously
through December 1, 2025. NIST is
taking this action to provide additional
time for interested parties to join the
Consortium to further pursue the
implementation and achievement of
outcomes of the current Consortium
activities, as well as to address
additional standards needs as defined
by the Consortium in qualification of
off-target assays and quality of genome
editing components. Beginning January
1, 2026 participation fees will increase
to $25,000 annually or in-kind
contributions of equivalent value.
Participants will be required to sign a
Cooperative Research and Development
Agreement (CRADA).
DATES: The Consortium’s activities will
continue as needed to complete the
updated research plan. NIST will accept
letters of interest to participate in this
Consortium on an ongoing basis.
Acceptance of participants into the
Consortium will depend on the
availability of resources.
ADDRESSES: Information in response to
this notice, including completed letters
of interest or requests for additional
information about the Consortium, can
be directed via mail to the Consortium
Manager, Dr. Samantha Maragh,
Biosystems and Biomaterials Division of
NIST’s Material Measurement
Laboratory, 100 Bureau Drive, Mail Stop
8312, Gaithersburg, Maryland 20899 or
via electronic mail to samantha@
nist.gov, or by telephone at (301) 975–
4947.
SUPPLEMENTARY INFORMATION: On
January 11, 2018, NIST published a
notice in the Federal Register (83 FR
1335), establishing the Consortium, and
on February 2, 2021, NIST published a
notice in the Federal Register (86 FR
7859) extending the duration of the
Consortium until December 1, 2025. To
provide additional time for interested
parties to join the Consortium to further
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:48 Oct 22, 2024
Jkt 265001
pursue the implementation and
achievement of the Consortium
objectives, NIST extends the term to
continue as needed to complete the
updated research plan and will accept
letters of interest on an ongoing basis.
Previously submitted letters of interest
do not need to be resubmitted.
The Consortium’s current activities
(as described in the original notice, 83
FR 1335) will continue, and the
Consortium research plan is amended to
include the following new activities:
Qualification of Off-Target Assays:
Identify sources of variability and
develop consensus approaches to
qualifying off-target assays (including
potential interlaboratory studies or
control materials).
Quality of Genome Editing
Components: Identify concepts/
information, approaches/assays, and
potential controls for assessing quality
of genome editing components.
[FR Doc. 2024–24514 Filed 10–22–24; 8:45 am]
BILLING CODE 3510–13–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
[RTID 0648–XE356]
Takes of Marine Mammals Incidental to
Specified Activities; Taking Marine
Mammals Incidental to Pile Driving
Training Exercises at Naval Base
Ventura County, Port Hueneme
National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Notice; proposed issuance of an
incidental harassment authorization;
request for comments on proposed
authorization and possible renewal.
AGENCY:
NMFS has received a request
from the United States Navy (Navy) for
authorization to take marine mammals,
by Level B harassment only, incidental
to pile driving training exercises at
Naval Base Ventura County, Port
Hueneme (NBVC).
NMFS previously issued an incidental
harassment authorization IHA to the
Navy for similar activities on April 28,
2023 (hereinafter referred to as the
initial IHA); however, during the initial
authorization period, only one of four
planned training exercise was
performed. The Navy is requesting, and
NMFS is proposing to issue an IHA
authorizing incidental take for an
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
Comments and information must
be received no later than November 7,
2024.
DATES:
Alicia Chambers,
NIST Executive Secretariat.
SUMMARY:
additional four training exercises.
Pursuant to the Marine Mammal
Protection Act (MMPA), NMFS is
requesting comments on its proposal to
issue an IHA to incidentally take marine
mammals during the specified activities.
NMFS is also requesting comments on
a possible 1-year Renewal IHA that
could be issued under certain
circumstances and if all requirements
are met, as described in Request for
Public Comments at the end of this
notice. NMFS will consider public
comments prior to making any final
decision on the issuance of the
requested MMPA authorizations and
agency responses will be summarized in
the final notice of our decision. The
Navy’s activities are considered military
readiness activities pursuant to the
MMPA, as amended by the National
Defense Authorization Act for Fiscal
Year 2004 (NDAA).
Comments should be
addressed to Jolie Harrison, Chief,
Permits and Conservation Division,
Office of Protected Resources, National
Marine Fisheries Service, and should be
submitted via email to
ITP.tyson.moore@noaa.gov. Electronic
copies of the application and supporting
documents, as well as a list of the
references cited in this document, may
be obtained online at: https://
www.fisheries.noaa.gov/permit/
incidental-take-authorizations-undermarine-mammal-protection-act. In case
of problems accessing these documents,
please call the contact listed below.
Instructions: NMFS is not responsible
for comments sent by any other method,
to any other address or individual, or
received after the end of the comment
period. Comments, including all
attachments, must not exceed a 25megabyte file size. All comments
received are a part of the public record
and will generally be posted online at
https://www.fisheries.noaa.gov/permit/
incidental-take-authorizations-undermarine-mammal-protection-act without
change. All personal identifying
information (e.g., name, address)
voluntarily submitted by the commenter
may be publicly accessible. Do not
submit confidential business
information or otherwise sensitive or
protected information.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Reny Tyson Moore, Office of Protected
Resources, NMFS, (301) 427–8401.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23OCN1.SGM
23OCN1
Agencies
[Federal Register Volume 89, Number 205 (Wednesday, October 23, 2024)]
[Notices]
[Page 84534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24514]
[[Page 84534]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
National Institute of Standards and Technology
NIST Consortium for Advancement of Genome Editing
AGENCY: National Institute of Standards and Technology, Department of
Commerce.
ACTION: Notice of Research Consortium; Extension of Research
Consortium.
-----------------------------------------------------------------------
SUMMARY: The National Institute of Standards and Technology (NIST)
extends the duration of the NIST Consortium for Advancement of Genome
Editing (Genome Editing Consortium or Consortium). The Consortium
duration was previously through December 1, 2025. NIST is taking this
action to provide additional time for interested parties to join the
Consortium to further pursue the implementation and achievement of
outcomes of the current Consortium activities, as well as to address
additional standards needs as defined by the Consortium in
qualification of off-target assays and quality of genome editing
components. Beginning January 1, 2026 participation fees will increase
to $25,000 annually or in-kind contributions of equivalent value.
Participants will be required to sign a Cooperative Research and
Development Agreement (CRADA).
DATES: The Consortium's activities will continue as needed to complete
the updated research plan. NIST will accept letters of interest to
participate in this Consortium on an ongoing basis. Acceptance of
participants into the Consortium will depend on the availability of
resources.
ADDRESSES: Information in response to this notice, including completed
letters of interest or requests for additional information about the
Consortium, can be directed via mail to the Consortium Manager, Dr.
Samantha Maragh, Biosystems and Biomaterials Division of NIST's
Material Measurement Laboratory, 100 Bureau Drive, Mail Stop 8312,
Gaithersburg, Maryland 20899 or via electronic mail to
[email protected], or by telephone at (301) 975-4947.
SUPPLEMENTARY INFORMATION: On January 11, 2018, NIST published a notice
in the Federal Register (83 FR 1335), establishing the Consortium, and
on February 2, 2021, NIST published a notice in the Federal Register
(86 FR 7859) extending the duration of the Consortium until December 1,
2025. To provide additional time for interested parties to join the
Consortium to further pursue the implementation and achievement of the
Consortium objectives, NIST extends the term to continue as needed to
complete the updated research plan and will accept letters of interest
on an ongoing basis. Previously submitted letters of interest do not
need to be resubmitted.
The Consortium's current activities (as described in the original
notice, 83 FR 1335) will continue, and the Consortium research plan is
amended to include the following new activities:
Qualification of Off-Target Assays: Identify sources of variability
and develop consensus approaches to qualifying off-target assays
(including potential interlaboratory studies or control materials).
Quality of Genome Editing Components: Identify concepts/
information, approaches/assays, and potential controls for assessing
quality of genome editing components.
Alicia Chambers,
NIST Executive Secretariat.
[FR Doc. 2024-24514 Filed 10-22-24; 8:45 am]
BILLING CODE 3510-13-P